Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway

@article{Fife2006InsulininducedRI,
  title={Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway},
  author={Brian T Fife and Indira Guleria and Melanie Gubbels Bupp and Todd N. Eagar and Qizhi Tang and H{\'e}l{\`e}ne Bour-Jordan and H. Yagita and Miyuki Azuma and Mohamed H. Sayegh and Jeffrey A Bluestone},
  journal={The Journal of Experimental Medicine},
  year={2006},
  volume={203},
  pages={2737 - 2747}
}
The past decade has seen a significant increase in the number of potentially tolerogenic therapies for treatment of new-onset diabetes. However, most treatments are antigen nonspecific, and the mechanism for the maintenance of long-term tolerance remains unclear. In this study, we developed an antigen-specific therapy, insulin-coupled antigen-presenting cells, to treat diabetes in nonobese diabetic mice after disease onset. Using this approach, we demonstrate disease remission, inhibition of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 131 extracted citations

Foxp3+ Regulatory T Cells in Mouse Models of Type 1 Diabetes

Journal of diabetes research • 2013
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.

Proceedings of the National Academy of Sciences of the United States of America • 2005

Similar Papers

Loading similar papers…